Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer

Autor: Bengio, Ruben, Cutuli, Hernan, Salinas, Jorge, Ameye, Filip, Joniau, Steven, Rodrigues da Rosa, Diogo, Martins da Trindade, Karine, Luz, Murilo Almeida, Bavaresco, Mario Henrique, de Paula, Adriano, Santiag, Jose, Wang, Shaogang, Ye, Dingwei, Boegemann, Martin, Roghmann, Florian, Heidrich, Albert, Hellmis, Eva, Faba, Óscar Rodriguez, Dominguez, Jose Luis, Mathieu, Romain, Colombel, Marc, Bladou, Franck, Artignan, Xavier, Vasdev, Nikhil, Shimpi, Rajendra, Guadalupi, Valentina, Tambaro, Rosa, Sirotova, Zuzana, Spada, Massimiliano, Necchi, Andrea, Nakatsu, Hiroomi, Kikuchi, Eiji, Shimizu, Nobuaki, Kanao, Kent, Sumitomo, Makoto, Naito, Yushi, Ham, Won Sik, Jung, Seung-Il, Ha, Hongkoo, Joo, Kwan Joong, Ku, Ja Hyeon, Seo, Ho Kyung, Yun, Seokjoong, Kolodziej, Anna, Lawinski, Janusz, Morris, David, Daneshmand, Siamak, Mian, Badar, Lee, Eugene, Catto, J.W.F., Tran, B., Rouprêt, M., Gschwend, J.E., Loriot, Y., Nishiyama, H., Redorta, J.P., Daneshmand, S., Hussain, S.A., Cutuli, H.J., Procopio, G., Guadalupi, V., Vasdev, N., Naini, V., Crow, L., Triantos, S., Baig, M., Steinberg, G.

Publikováno v: In Annals of Oncology January 2024 35(1):98-106